Repeated B-cell depletion with rituximab in rheumatoid arthritis

類似資料

• Internalization of Rituximab and the Efficiency of B Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus
  著者:: Reddy, Venkat, 等
  出版事項: (2015)
• Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion
  著者:: Leandro, M, 等
  出版事項: (2002)
• B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience
  著者:: Shaw, T, 等
  出版事項: (2003)
• B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis
  著者:: Tuscano, Joseph M, 等
  出版事項: (2009)
• Depletion of B‐Cells With Rituximab Improves Endothelial Function and Reduces Inflammation Among Individuals With Rheumatoid Arthritis
  著者:: Hsue, Priscilla Y., 等
  出版事項: (2014)